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ABSTRACT 47 
Caffeine metabolites in wastewater were investigated as potential biomarkers for 48 
assessing caffeine intake in a population. The main human urinary metabolites of caffeine 49 
were measured in the urban wastewater of ten European cities and the metabolic profiles in 50 
wastewater were compared with the human urinary excretion profile. A good match was 51 
found for 1,7-dimethyluric acid, an exclusive caffeine metabolite, suggesting that might be a 52 
suitable biomarker in wastewater for assessing population-level caffeine consumption. A 53 
correction factor was developed considering the percentage of excretion of this metabolite in 54 
humans, according to published pharmacokinetic studies. Daily caffeine intake estimated 55 
from wastewater analysis was compared with the average daily intake calculated from the 56 
average amount of coffee consumed by country per capita. Good agreement was found in 57 
some cities but further information is needed to standardize this approach. Wastewater 58 
analysis proved useful to providing additional local information on caffeine use. 59 
 60 
Key words: Caffeine; 1,7-dimethyluric acid; back-calculation; correction factor; wastewater-61 
based epidemiology; urinary biomarkers 62 
 63 
 64 
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1. INTRODUCTION 65 
History suggests that caffeine has been used, in one form or another, since ancient 66 
times. In 2737 BC a Chinese Emperor used the leaves from a nearby bush to prepare a tea 67 
(Arab and Blumberg, 2008; Heckman et al., 2010). An old legend dates the use of coffee to 68 
the 9th century in the southern tip of the Arabian Peninsula when a shepherd noted euphoria 69 
and stimulating effects on his goats caused by eating wild coffee berries. He then decided to 70 
try them himself. Coffee later crossed to Africa and in the 1600s reached Europe becoming, 71 
over the centuries, the most commonly consumed beverage worldwide after water (Butt and 72 
Tauseef, 2011). 73 
Caffeine is a naturally occurring alkaloid found in beans, leaves and fruits of more 74 
than 60 plant species. The world’s main sources are coffee beans (Coffea arabica and Coffea 75 
robusta) and tea leaves (Camellia siniensis). It is also naturally found in kola nuts (Cola 76 
acuminate), cocao beans (Theobroma cacao), yerba mate (Ilex paraguariensis) and guarana 77 
berries (Paullinia cupana). Most caffeine is consumed with beverages such as coffee, tea and 78 
soft drinks (including “energy drinks”), while products containing cocoa or chocolate, and 79 
medications such as some analgesic formulations and dietary supplements contribute small 80 
amounts to the diet (Heckman et al., 2010). Total daily intakes vary throughout the world 81 
although coffee usually contributes significantly more than other drinks to overall caffeine 82 
consumption (coffee 71%, soft drinks 16% and tea 12%), particularly among adults 83 
(Heckman et al., 2010; Mitchell et al., 2014). Carbonated Soft drinks are the main source of 84 
caffeine for children (Mitchell et al., 2014).  85 
Chocolate contains on average around 1.3% of theobromine, 0.75% of caffeine and 86 
theophylline in small amounts; cola nut between 2 and 3.5% of caffeine, theobromine 87 
(between 1 and 3.5%) and small amounts of theophylline, and tea leaves around 3% of 88 
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caffeine (theophylline and theobromine in small amounts). This results in around 40-80 mg of 89 
caffeine per cup of tea (150 mL) while caffeine content in cocoa commercial products ranges 90 
from 2 to 7 mg (Barone and Roberts, 1996) and 5-20 mg/100 g in chocolate candy products. 91 
In soft drinks, variable levels of caffeine have been reported depending on the brand but the 92 
typical content is around 40 mg/360 mL (Chou and Bell, 2007). All these products contain 93 
relatively little caffeine compared to the average content of a coffee cup (60-150 mg/150 mL).  94 
Caffeine is extensively metabolized by the human liver to form three major 95 
metabolites by demethylation: 3,7-dimethylxanthine (known as theobromine), 1,7-96 
dimethylxanthine (paraxanthine) and 1,3-dimethylxanthine (theophylline). These are then 97 
broken down further in the liver by additional demethylation and oxidation and are excreted 98 
mostly in the urine (Heckman et al., 2010).  99 
While there is no specific recommendation for human caffeine intake, it is considered 100 
that average consumption of approximately 300 mg/day is not associated with adverse health 101 
effects (Fitt et al., 2013; Higdon and Frei, 2006). However, data about caffeine intake in the 102 
population are scarce. Caffeine consumption is usually assessed by dietary surveys, but 103 
getting accurate information in this way presents many limitations. For instance, subjects may 104 
under-report their caffeine intake when food diaries are completed or information is missing 105 
about the strength, brand or amount of caffeine product they have consumed, which may 106 
greatly affect the intake.  Another limitation is that in caffeine dietary surveys the subjects are 107 
usually asked about the consumption of certain beverages (mainly coffee and tea) but other 108 
products containing caffeine are not considered: for example, analgesics can contain as much 109 
as 200 mg caffeine per tablet (Derbyshire and Abdula, 2008). Another limitation for 110 
estimating the total caffeine intake is that the caffeine content of various drinks, food and 111 
dietary supplements is only known in some countries such as the USA (Fitt et al., 2013).  112 
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A complementary method would be to estimate consumption in the general population 113 
by using the levels of caffeine and its metabolites measured in urban wastewater as 114 
biomarkers of intake. This approach, called wastewater-based epidemiology (WBE), has been 115 
mainly applied in the last decade for estimating illicit drug consumption (Baker et al., 2014; 116 
Ort et al., 2014; Thomas et al., 2012; Zuccato et al., 2008) and more recently has also been 117 
proposed for the quantitative measurement of lifestyle habits such as tobacco and alcohol use, 118 
exposure to environmental and food contaminants or factors related to health and illness in a 119 
community (Lopes et al., 2014; Reid et al., 2011; Rodríguez-Álvarez et al., 2015; Rousis et 120 
al., 2017; Thomas and Reid, 2011; Yang et al., 2015). The main advantage of WBE is that it 121 
provides objective, up-to-date information about the use of these substances in a population 122 
and can therefore complement current epidemiological methods. 123 
In this study, the presence of caffeine and some selected metabolites was assessed in 124 
untreated wastewater in ten European cities. Levels in wastewater were compared with those 125 
measured in urine and with the human excretion profiles of caffeine reported in the literature 126 
in order to correlate the results from the different sources. 1,7-dimethyluric acid, an exclusive 127 
caffeine metabolite, was selected for estimating collective caffeine consumption. The 128 
reliability of this compound for caffeine back-calculation was evaluated by comparing the 129 
amounts measured by wastewater analysis with the average amount of coffee consumed in 130 
each country per capita. 131 
 132 
2. MATERIALS AND METHODS 133 
2.1  Chemicals and reagents 134 
Caffeine (1,3,7-trimethlxanthine), paraxanthine and 1-methylxanthine were purchased 135 
from Sigma Aldrich (St. Louis, MO, USA); 1-methyluric acid, 1,7-dimethyluric acid 7-136 
methylxanthine were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, California, 137 
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USA). Standard solutions at 1 mg/mL were prepared in methanol, except for 1-138 
methylxanthine, 7-methylxanthine, paraxanthine and 1,7-dimethyluric acid which were 139 
prepared in methanol-water (50/50) at pH 8.5-10 (adjusted with 25% ammonia to enhance 140 
solubility). A mix of all compounds at 10 ng/µL was prepared in methanol and then diluted to 141 
1.0, 0.1 and 0.01 ng/µL. Isotopically labeled compounds were caffeine-13C3 purchased from 142 
Sigma Aldrich and 1,7-dimethyluric acid-d3 from Santa Cruz Biotechnology. Labeled internal 143 
solutions were prepared separately.  Internal standard mixtures with 1 ng/µL of caffeine-13C3 144 
and 10 ng/µL of 1,7-dimethyluric acid-d3 were used as surrogates.  145 
All solvents were of reagent grade or higher. Methanol for pesticide analysis and 146 
ammonium acetate were from Carlo Erba Reagents (Italy). Ammonium hydroxide solution 147 
(25%) was acquired from Fluka (Buchs, Switzerland). LC-MS grade acetonitrile and 148 
hydrochloric acid (37%) were supplied by Riedel de Haen (Seelze, Germany). Water was 149 
purified using Milli-RO Plus 90 apparatus (Millipore, Molsheim, France). Solid-phase 150 
cartridges (3 mL Oasis HLB, 60 mg) and HPLC XTerra C18 column (3.5 μm, 1 mm × 100 151 
mm) were obtained from Waters Corp., Milford, MA, USA. 152 
 153 
2.2 Wastewater samples 154 
24-hour composite influent wastewater samples were collected from ten wastewater 155 
treatment plants (WWTP) in different European cities: Bristol (UK), Brussels (Belgium), 156 
Castellón (Spain), Copenhagen (Denmark), Lugano (Switzerland), Milan (Italy), Oslo 157 
(Norway), Porto (Portugal), Utrecht (Netherlands) and Zurich (Switzerland) (Table S2). 158 
Samples were collected daily for seven consecutive days in March 2015 and April 2015 159 
(Porto), frozen immediately after collection to prevent degradation of the compounds and sent 160 
to Milan within 24 hours in cooler boxes with dry ice or ice packs to keep them frozen. 161 
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Samples were stored at -20°C until analysis. For each sample the flow rate of the sewage 162 
stream (L/day) was recorded. 163 
 164 
2.3 Extraction and analysis 165 
Before solid phase extraction, samples were thawed in a warm bath, then filtered to 166 
remove suspended particulate matter through 1.6 µm GF/A glass microfiber filters and 0.45 167 
µm mixed cellulose membrane filters from Whatman (Kent, UK). Then 3 mL of filtered 168 
wastewater were spiked with labeled internal standards (20 ng of caffeine-13C3 and 200 ng 169 
1,7-dimethyluric acid-d3) and, if necessary, the pH was adjusted to 6.0-7.5 with 12% HCl 170 
(v/v). Samples were loaded on Oasis HLB cartridges (3 mL, 60 mg), previously conditioned 171 
with 6 mL of MeOH and 3 mL of water. Cartridges were vacuum-dried for 10 minutes, 172 
wrapped in aluminum foil and immediately stored at -20 °C. For analysis, cartridges were 173 
eluted with 2 mL of methanol and the extract was evaporated to dryness under a nitrogen 174 
stream. Dry residues were redissolved in 100 µL MeOH-ultrapure water (20:80, v/v), 175 
centrifuged and transferred into glass vials for instrumental analysis. One µL of the final 176 
extract was injected into the liquid chromatography coupled to tandem mass spectrometry 177 
system (LC–MS/MS). The analyses were done by high-performance liquid chromatography 178 
(1200 Series pumps system, Agilent Technologies, CA) coupled to a triple quadrupole mass 179 
spectrometer (AB SCIEX QqQ 5500, Ontario, Canada). Samples were analysed using the 180 
positive electrospray ionization mode. Experimental conditions and detailed analytical 181 
conditions are described in Table S3 and S4 and in more detail in Senta et al., 2015. 182 
 183 
2.4. Daily mass loads and back-calculation of consumption 184 
9 
 
The daily mass loads (g/day) of the selected analytes were calculated multiplying the 185 
measured concentrations of caffeine and metabolites (ng/L) by the daily flow rate of 186 
wastewater (L/day) at the entry of each WWTP. 187 
Caffeine consumption was back-calculated using the approach proposed for illicit 188 
drugs by Zuccato et al., 2008. Specific correction factors were developed taking into account 189 
the percentage of urinary excretion of each metabolite and the molar mass ratio of the parent 190 
compound to the metabolite. All the pharmacokinetic studies accessible in the literature which 191 
reported data on the human urinary excretion of caffeine after oral administration (eight in all, 192 
see Supplemental Information) were reviewed to develop a specific correction factor for 193 
back-calculating caffeine intake by the population. The mean percentage of excretion of 194 
caffeine and its metabolites was calculated by weighting the number of subjects in each study. 195 
The total uncertainty related to the back-calculation procedure was evaluated as the standard 196 
deviation (SD) of the mean percentage of excretion (Table 1). This method had been 197 
previously proposed for refining the correction factors of the most used illicit drugs 198 
(Castiglioni et al., 2013; Gracia-Lor et al., 2016). 199 
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Table 1. Metabolic profiles of caffeine and its main metabolites in human urine (from pharmacokinetic studies and spot urine analysis) and from 200 
the levels measured in wastewater. 201 
Compound 
Mean excretion (%) from 
pharmacokinetic studies 
(SD) 
Geometric mean from spot 
urine analysis (95%CI) (2466 
subjects)a 
Mean excretion (%) from 
wastewater analysis (SD) 
 (70 samples) 
caffeine (1,3,7-trimethylxanthine) 1.7 (1.0) 1.81 (1.57-2.08) 20.9 (6.0) 
paraxanthine (1,7-dimethylxanthine) 4.6 (1.4) 7.47 (6.73-8.29) 22.1 (4.0) 
1-methylxanthine 10.0 (3.4) 17.1 (15.4-19.0) 15.8 (3.5) 
7-methylxanthine 3.1 (1.2) 31.4 (28.6-34.3) 24.9 (6.4) 
1-methyluric acid 16.5 (6.2) 39.4 (35.8-43.4) 4.7 (1.1) 
1,7-dimethyluric acid 6.7 (2.3) 12.2 (11.0-13.6) 11.6 (2.0) 
theophylline (1,3-dimethylxanthine) 0.6 (0.4) 0.872 (0.796-0.955) Not analyzed 
theobromine (3,7-dimethylxanthine) 1.5 (1.3) 12.4 (11.4-13.5) Not analyzed 
1,3-dimethyluric acid 1.6 (0.7) 3.51 (3.17-3.89) Not analyzed 
3,7-dimethyluric acid 0.2 (0.4) 0.784 (0.714-0.861) Not analyzed 
3-methylxanthine 2.0 (1.1) 19.2 (17.5-21.0) Not analyzed 
 202 
aData taken from Rybak et al., 2014 203 
 204 
11 
 
3. RESULTS AND DISCUSSION 205 
3.1 Caffeine biomarkers for back-calculation 206 
Selecting a substance as a biomarker is not easy to achieve as it must have specific 207 
characteristics (Gracia-Lor et al., 2016): i) be excreted in measurable quantities in wastewater; 208 
ii) be released to sewers exclusively from human excretion; iii) be unique to human 209 
metabolism to ensure that it comes only from human excretion and not from exogenous 210 
sources; iv) have low adsorption for suspended particulate; v) be stable in wastewater during 211 
in-sewer transport, and during storage and analysis. 212 
Each substance for this investigation was tested as a suitable biomarker of caffeine 213 
consumption as described above. Caffeine itself is not a good candidate because it comes not 214 
only from coffee but also from other sources. Caffeine metabolites too may originate from 215 
other naturally occurring alkaloids with similar structures, such as theobromine and 216 
theophylline, which themselves are also caffeine metabolites (Figure 1). Theobromine is 217 
present in cocoa beans (and subsequently in chocolate), tea leaves and cola beans. 218 
Theophylline is present in tea leaves in small amounts but is also used medically, for instance 219 
for asthma and other lung diseases (Senchina et al., 2014). Specifically, among five caffeine 220 
metabolites studied, 1-methylxanthine and 1-methyluric acid are also metabolites of 221 
theophylline, while 7-methylxanthine is the major metabolite of theobromine. Paraxanthine 222 
and 1,7-dimethyluric acid however, are exclusively metabolites of caffeine (Figure 1). Thus, 223 
they are potentially the most suitable biomarkers to back-calculate the amount of caffeine 224 
consumed, i.e. the consumption of all products containing caffeine (coffee, chocolate, tea, 225 
etc). As they come only from human excretion and not from exogenous sources, their 226 
presence can play an important role in identifying fresh water or ground water contaminated 227 
by sewage. 228 
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Figure 1. Metabolic pathway of caffeine in humans 231 
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 232 
3.2 Metabolic profiles in wastewater and in human urine 233 
According to the human urinary excretion profile of caffeine, the mass loads of 1-234 
methyluric acid should be the highest, followed by 1-methylxanthine, 1,7-dimethyluric acid, 235 
paraxanthine, 7-methylxanthine  and finally, caffeine (Table 1). However, the quantitative 236 
profiles of caffeine and the metabolites calculated from wastewater analysis did not 237 
completely agree with the human excretion profile. The mass loads (mean of the ten cities) 238 
decreased as follows: 7-methylxanthine > paraxanthine > caffeine > 1-methylxanthine > 1,7-239 
dimethyluric acid > 1-methyluric acid (Figure 2). Hence, there are large differences from the 240 
human excretion profile of caffeine. We therefore included supplementary data from spot 241 
urine analysis in our comparison (Table 1). These percentages (geometric mean, 95% CI) 242 
were obtained from Rybak et al., 2014, who recently measured caffeine and 14 metabolites in 243 
more than 2000 urine samples. We calculated also the percentages of excretion using the 244 
concentrations measured in wastewater in the ten European cities (Table 1). Each metabolite 245 
is reported as a percentage of the sum of the levels of metabolites plus caffeine measured in 246 
wastewater, following the procedure employed by Castiglioni et al., 2011 to calculate the 247 
metabolic profile of cocaine in wastewater and in human urine. The excretion profiles of 248 
caffeine and its metabolites were calculated using median values because of the high 249 
variability of the concentrations.  250 
 251 
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Figure 2. Normalized mass loads (g/day/1000 inhabitants) of caffeine and its metabolites in 254 
ten European cities in March 2015 and April 2015 (Porto). Means ± standard deviation (SD) 255 
of seven-day samples (only the upper limit of the SD bar is shown). 256 
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Data from wastewater could be reasonably compared with the profiles in spot urine 257 
samples, since they indicate respectively the profiles of excretion from an entire community 258 
and from single individuals. Percentages were comparable for 1-methylxanthine and 7-259 
methylxanthine acid in wastewater and spot urine samples, but higher than in 260 
pharmacokinetic studies (Table 1). This can be easily explained by the fact that they are also 261 
metabolites of theophylline and theobromine respectively. The percentage of caffeine in 262 
wastewater (21%) was much higher than expected from spot urine analysis and 263 
pharmacokinetic studies (1.8% and 1.7%). There might therefore be other sources of caffeine 264 
contributing to the total amount in wastewater (e.g., coffee grounds that are disposed down of 265 
the sink drain, disposal of coffee that was not drunk or improper disposal of caffeine for 266 
pharmacological use). In contrast, for 1-methyluric acid the percentage in wastewater was 267 
lower than in urine and in pharmacokinetic studies. A possible explanation could be 268 
degradation of this compound in wastewater such as in-sewer, during transport or during 269 
storage. This should be verified by in-sewer experiments and additional modeling studies.  270 
Some differences were observed for paraxanthine (22.1% of the total in wastewater, 271 
4.6% in pharmacokinetic studies and 7.5% in spot urine samples); however for 1,7-272 
dimethyluric acid the results were comparable (approximately 12% of the measured 273 
concentrations in wastewater and in spot urine samples, and 4.3-12.6% of the administered 274 
dose in pharmacokinetic studies (see data in SI)). Taking to account of all these 275 
considerations, 1,7-dimethyluric acid seemed to be the most suitable biomarker for the back-276 
calculation of caffeine. The mean percentage of excretion of this metabolite weighted by the 277 
number of subjects in each study (6.7%) and the 1,7-dimethyluric acid/caffeine molecular 278 
mass ratio were used to obtain the correction factor (CF), according to the following equation: 279 
 280 
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where Mw is the molecular weight and the mean excretion is the weighted mean of the 281 
percentage of excretion of  the target metabolite. 282 
 283 
3.3 Estimation of caffeine consumption 284 
Using the proposed correction factor, caffeine consumption (in mg/day/person) in 285 
each city was calculated based on the wastewater measurements of 1,7-dimethyluric acid. The 286 
mean daily consumption of caffeine per capita ranged from 263 mg/day/person in Zurich to 287 
87 mg/day/person in Milan (Table 2). These data match the mean daily caffeine intake in 288 
Europe of around 300 mg/day/person estimated by the European Food Safety Authority 289 
(means range from 37 to 320 mg/day/person estimated from individual surveys for adults 290 
between 18 and 64 years) (European Food Safety Authority (EFSA), 2015). 291 
For a more accurate comparison, we compared our wastewater analysis data to the 292 
amount of coffee consumed per country per capita (per person on average), which reflects the 293 
imports of coffee by each country, according to the International Coffee Organization (ICO) 294 
(International Coffee Organization (ICO), 2015). We converted the per capita consumption 295 
(in kg/person) of coffee to the daily intake of caffeine per person considering that dry coffee 296 
beans contain about 1.1% of caffeine in Arabica and about 2.2% in Robusta coffee. In 2015, 297 
around 60% of the coffee exported was Arabica (“International Coffee Organization,” 2015), 298 
but the proportion can change from country to country. For instance, according to Garattini, 299 
1993, consumer countries can be classified in three levels: (a) where consumption of Arabica 300 
accounts for more than 70% (Switzerland and Northern European countries, i.e. Norway and 301 
Denmark); (b) where consumption of Arabica is around 50% (Italy, the Netherlands, Belgium 302 
and the UK); (c) where consumption of Robusta predominates (Spain and Portugal) (Table 303 
2). In addition, the amount of caffeine extracted varies with the preparation method, ranging 304 
from 75% in boiled coffee to nearly 100% in filtered coffee. To estimate the amount of 305 
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caffeine in the coffee we took 1.1% for countries classified in group (a), 1.6% (i.e. mean 306 
caffeine content in Arabica and in Robusta) for countries belonging to group (b) and 2.2% for 307 
countries in group (c). In all cases, we assumed 95% extraction efficiency, as previously 308 
proposed (Fredholm et al., 1999).  309 
For four cities (Oslo, Copenhagen, Zurich and Brussels), the difference was 20% or 310 
less. The amounts for Castellón, Utrecht, Milan, Lugano and Porto estimated from wastewater 311 
analysis were lower than indicated by the coffee trade figures, and higher in Bristol. This 312 
might be due to different factors: first of all, we compared data from whole country with data 313 
in a specific city, while population habits might be different. This was the case for Zurich and 314 
Lugano, two Swiss cities: a 20% difference was obtained for Zurich (410,000 inhabitants), 315 
whilst it was around 50% for Lugano (100,000 inhabitants). Secondly, we compared annual 316 
coffee trade figures with caffeine estimated through wastewater analysis in one week. Finally, 317 
data obtained through back-calculation refer to the amount of caffeine consumed in all 318 
products that contain relatively large amounts such as coffee, chocolate, soft drinks and 319 
medications. Thus, larger amounts of caffeine estimated through the wastewater analysis in 320 
Zurich, Copenhagen, and especially in Bristol, might be due to higher consumption of other 321 
products in those countries. Switzerland is in fact the country with the highest per capita 322 
consumption of chocolate, and the UK is also among the countries with the highest 323 
consumption, according to different sources (Statista, 2015; Target Map, 2015)). Another 324 
reason might be the fact that the caffeine content of coffee in the UK is higher than in other 325 
countries (Barone and Roberts, 1996). Furthermore, tea containing around 3% of caffeine is 326 
the most popular drink in the UK today, and contributes to caffeine consumption. In five 327 
cities, the difference was of at least 50%. 328 
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Table 2. Caffeine consumption estimated from wastewater analysis and using coffee trade data for the countries investigated. The difference was 329 
calculated between the estimates from international statistics and from wastewater analysis. 330 
 Caffeine from 
wastewater analysis 
Caffeine from international statistics* 
Difference (%) 
Cities investigated 
(country) 
mg caffeine/day/person 
(SD) 
Kg coffee/year/person* 
Type of coffee mostly 
consumeda 
mg caffeine/day/person 
Bristol (UK) 190 (37) 3.3 50% Arabica-50% Robusta 137 -38 
Brussels (Belgium) 162 (15) 4.3 50% Arabica-50% Robusta 179 16 
Castellón (Spain) 122 (28) 4.5 Robusta 258 53 
Copenhagen (Denmark) 229 (19) 6.9 Arabica 198 -16 
Lugano (Switzerland) 97 (16) 7.6 Arabica 218 55 
Milan (Italy) 86 (18) 5.6 50% Arabica-50% Robusta 233 63 
Oslo (Norway)  211 (21) 8.7 Arabica 249 15 
Porto (Portugal) 121 (27) 4.8 Robusta 275 56 
Utrecht (The Netherlands) 107 (28) 5.3 50% Arabica-50% Robusta 221 51 
Zurich (Switzerland) 263 (23) 7.6 Arabica 218 -20 
 331 
*Source: International Coffee Organization (ICO), 2015 (http://www.ico.org/coffee-trade-statistics-infographics.asp) 332 
a(Garattini, 1993) 333 
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The aim of the comparison between the amount of caffeine consumed, estimated from 334 
the wastewater analysis, and coffee consumption figures from international trade was mainly 335 
to check whether the proposed metabolite was a suitable biomarker of consumption. The 336 
results indicate that 1,7-dimethyluric acid can be used for this purpose, although additional 337 
studies are needed to validate this approach, including more extensive wastewater sampling 338 
campaigns in different countries.  339 
Additional information on the current proportions (percentages) of commercial 340 
varieties of coffee consumed in each country is also needed for more accurate comparisons. 341 
There are some differences between coffee consumption data, in terms of the amount 342 
consumed in each country per capita, published by different sources (for instance, between the 343 
ICO (International Coffee Organization (ICO), 2015) which is based on coffee imports and 344 
exports and Euromonitor International (Caffeine Informer, 2016), which deals with local 345 
business information). This is another factor that may influence the accuracy of a data 346 
comparison.  347 
Additionally, only eight studies could be found dealing with the human excretion of 348 
caffeine, so more pharmacological studies are essential to improve the reliability of urinary 349 
excretion profiles and the correction factors used to back-calculate caffeine consumption. At 350 
present, these studies are scarce and most are quite old and based on a small number of 351 
subjects (Gracia-Lor et al., 2016).   352 
 353 
4. CONCLUSIONS 354 
Profiles of caffeine metabolites in wastewater reasonably matched the profiles in spot 355 
urine samples suggesting that the analysis in wastewater might reflect the collective 356 
consumption of caffeine-containing products.  357 
We selected 1,7-dimethyluric acid for caffeine back-calculation because it is an 358 
exclusive human metabolite of caffeine and so it is only produced by consumption of products 359 
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containing caffeine (i.e. coffee, tea, chocolate, etc.). The percentage of its excretion from 360 
pharmacokinetic studies is similar to the profiles found in urine and in wastewater (estimated 361 
from 70 influent wastewater samples collected in ten European cities). The mean daily 362 
consumption of caffeine per capita, estimated from wastewater analysis using the correction 363 
factor proposed, matched the mean daily caffeine intake (from 37 to 320 mg/day/person 364 
estimated from individual surveys for adults 18-64 years old). In four cities a good correlation 365 
was seen between wastewater analysis and the amount of coffee consumed in the country per 366 
capita. Several factors might explain discrepancies in the other six cities. For instance the 367 
estimation of coffee consumption on the basis of the imports of coffee by each country is 368 
influenced by many uncertainties, so it is hard to estimate the consumption of other 369 
commodities contributing to caffeine intake. Furthermore, the correction factor may be 370 
imprecise due to uncertainties in the metabolism studies in the literature. Thus, new studies 371 
are needed about the metabolism and urinary excretion of caffeine in realistic intake amounts. 372 
Stability tests of biomarkers in sewers are also needed.  373 
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